SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-14-078641
Filing Date
2014-11-10
Accepted
2014-11-10 07:08:08
Documents
4
Period of Report
2014-11-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a14-24102_18k.htm 8-K 28361
2 EX-99.1 a14-24102_1ex99d1.htm EX-99.1 113809
3 GRAPHIC g241021mmi001.gif GRAPHIC 3691
4 GRAPHIC g241021mmi002.jpg GRAPHIC 1547
  Complete submission text file 0001104659-14-078641.txt   150822
Mailing Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459
Business Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459 617-658-0600
Karyopharm Therapeutics Inc. (Filer) CIK: 0001503802 (see all company filings)

IRS No.: 263931704 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36167 | Film No.: 141206541
SIC: 2834 Pharmaceutical Preparations